RESEARCHER PROFILE

Roberto Cauda

← Back to Università Cattolica del Sacro Cuore

R

Università Cattolica del Sacro Cuore

HIV Research and TreatmentHIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsHIV-related health complications and treatmentsAntibiotic Use and Resistance

Roberto Cauda works in HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, HIV-related health complications and treatments, Antibiotic Use and Resistance. Recorded institutional associations include Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico.

533Publications
20,851Citations
68H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Effects of chloroquine on viral infections: an old drug against today's diseases

    2003 · 1,268 citations
  2. Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

    2012 · 1,016 citations
  3. New insights into the antiviral effects of chloroquine

    2006 · 570 citations
  4. Infections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre study

    2015 · 511 citations
  5. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation

    1996 · 495 citations
  6. Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial Treatment

    2007 · 461 citations
  7. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis

    2007 · 435 citations
  8. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

    2022 · 394 citations
  9. Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused byKlebsiella pneumoniaeCarbapenemase–producingK. pneumoniae

    2018 · 354 citations
  10. Biofilm Production by Candida Species and Inadequate Antifungal Therapy as Predictors of Mortality for Patients with Candidemia

    2007 · 341 citations
  11. Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae : Risk Factors, Molecular Epidemiology, and Clinical Outcome

    2006 · 283 citations
  12. Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study

    2021 · 275 citations
  13. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study

    2014 · 267 citations
  14. Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy

    2020 · 255 citations
  15. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients

    2011 · 242 citations
  16. Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-β-Lactamase Production and Inadequate Initial Antibiotic Therapy

    2010 · 224 citations
  17. Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)

    2002 · 214 citations
  18. Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial

    2006 · 214 citations
  19. In Vitro and In Vivo Anticandidal Activity of Human Immunodeficiency Virus Protease Inhibitors

    1999 · 210 citations
  20. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy

    2001 · 206 citations
  21. Benefit of Appropriate Empirical Antibiotic Treatment: Thirty-day Mortality and Duration of Hospital Stay

    2006 · 199 citations
  22. Risk Factors and Outcomes of Candidemia Caused by Biofilm-Forming Isolates in a Tertiary Care Hospital

    2012 · 197 citations
  23. Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

    2009 · 194 citations
  24. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study

    2015 · 193 citations
  25. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

    2020 · 184 citations

← Return to the university profile